CN Stock MarketDetailed Quotes

600436 Zhangzhou Pientzehuang Pharmaceutical

Watchlist
  • 212.75
  • +5.73+2.77%
Market Closed Jul 31 15:00 CST
128.36BMarket Cap42.76P/E (TTM)

Zhangzhou Pientzehuang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhangzhou Pientzehuang Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 20, 2024

Revenue(YoY)

3.17B

+20.58%
EPS(YoY)

1.62

+26.56%
Analyst Rating

Strong Buy

Jul 31, 2024

Zhangzhou Pientzehuang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.657B--
--2024/Q3-- / 2.769B--
Aug 17, 20242024/Q22.480B / 3.116B--
Apr 20, 20242024/Q13.171B / 3.072B--
--2023/Q42.459B / 2.432B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.657B--
--2024/Q3-- / 2.769B--
Aug 17, 20242024/Q22.480B / 3.116B--
Apr 20, 20242024/Q13.171B / 3.072B--
--2023/Q42.459B / 2.432B--

Unlock Free Earnings Estimates

Zhangzhou Pientzehuang Pharmaceutical Earnings Reports

  • Announcement from Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. on semi-annual performance report for 2024.

    Jul 24 12:00 ET

  • Summary of the 2023 Annual Report of Zhangzhou Pianziying Pharmaceutical Co., Ltd.

    Apr 19 12:00 ET

  • Zhangzhou Pianziying Pharmaceutical Co., Ltd. 2023 Annual Report

    Apr 19 12:00 ET

  • Report for the first quarter of 2024 of Zhangzhou Pianziying Pharmaceutical Co., Ltd.

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Strong Buy

      65.22%

    • Buy

      34.78%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg